SASH1 is shown to be downregulated in breast cancer [40] and, when highly expressed, SASH1 can inhibit proliferation, invasion, and endothelial mesenchymal transition in other malignancies such as hepatocellular carcinoma and gastric cancer [41,42]. The gene discussed is SASH1; the disease is gastric cancer.